Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Craig Adam R, Chairman & CEO. Insider active across 2 companies, notably CTI Biopharma CORP. Cumulatively, 13 disclosures have been logged. Split: 2 buys · 1 sell. Total volume traded: €425k. Activity tracked since 30 June 2021. The latest transaction was disclosed on 12 August 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Craig Adam R
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5,000 shares@ US$2.1251.4% of flowcommon stockSEC:0000891293-21-000045:0
13 of 13 declarations
About Craig Adam R
Craig Adam R is President and CEO. He has 12 filings in total. In the 12 most recent filings, the reported buy volume is EUR 242219, the reported sell volume is EUR 0, and the date range runs from 2021-12-02 to 2025-10-27. The most frequent transaction nature is Option exercise.